Effect of preoperative pregabalin versus gabapentin on postoperative pain control after laparoscopic gastric bypass surgery
Khalid Abd El-Maksoud, M. Younes, Sherif A. Elokda
{"title":"Effect of preoperative pregabalin versus gabapentin on postoperative pain control after laparoscopic gastric bypass surgery","authors":"Khalid Abd El-Maksoud, M. Younes, Sherif A. Elokda","doi":"10.4103/asja.asja_21_16","DOIUrl":null,"url":null,"abstract":"© 2018 Ain-Shams Journal of Anaesthesiology | Publishe Background Perioperative gabapentin helps produce a significant opioid-sparing effect and probably also improves postoperative pain scores. Pregabalin is a novel drug with a heightened research interest in the analgesic, sedative, anxiolytic, and opioidsparingeffects, invariouspainsettings, includingpostoperativepain.We investigated pregabalin analgesic efficacy in morbid obese patients experiencing acute pain after laparoscopic gastric bypass surgery and compared it with gabapentin and placebo. Patients and methods A randomized, placebo-controlled study was conducted on 90 morbidly obese patients undergoing laparoscopic gastric bypass surgery. Patients were allocated into one of the three groups; the pregabalin group in which the patients received 300mg pregabalin, the gabapentin group in which the patients received 1200mg gabapentin, or the control group in which the patients received placebo 2h prior to surgery. Postoperative pain was controlled with intravenous fentanyl via patient controlled analgesia (PCA). Fentanyl consumption over 24 h and pain intensity measured by visual analogue score at rest (static) and during cough (dynamic) at recovery time, 1, 2, 6, 12, and 24h were recorded. Also sedation status, somnolence, dizziness, headache, nausea, and vomiting were monitored. Results Postoperative 24 h fentanyl consumption was significantly higher in the control group compared with both pregabalin and gabapentin groups (P<0.001). Pain intensity on visual analogue score (static and dynamic) was significantly higher in the control group compared with both pregabalin and gabapentin groups at time of recovery, 1, 2, 6, 12, and 24 h postoperatively. Numeric sedation score was significantly lower in the control group compared with pregabalin and gabapentin groups at time of recovery, 1, 2, and 6h postoperatively. No significant differences were found among the three groups as regards somnolence, dizziness, headache, nausea, and vomiting. Conclusion A single dose of 300mg pregabalin or 1200mg gabapentin given 2 h before surgery is better than placebo for postoperative pain control for laparoscopic gastric bypass surgery without significant side effects.","PeriodicalId":7492,"journal":{"name":"Ain-Shams Journal of Anaesthesiology","volume":"50 1","pages":"195 - 200"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ain-Shams Journal of Anaesthesiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/asja.asja_21_16","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
Abstract
© 2018 Ain-Shams Journal of Anaesthesiology | Publishe Background Perioperative gabapentin helps produce a significant opioid-sparing effect and probably also improves postoperative pain scores. Pregabalin is a novel drug with a heightened research interest in the analgesic, sedative, anxiolytic, and opioidsparingeffects, invariouspainsettings, includingpostoperativepain.We investigated pregabalin analgesic efficacy in morbid obese patients experiencing acute pain after laparoscopic gastric bypass surgery and compared it with gabapentin and placebo. Patients and methods A randomized, placebo-controlled study was conducted on 90 morbidly obese patients undergoing laparoscopic gastric bypass surgery. Patients were allocated into one of the three groups; the pregabalin group in which the patients received 300mg pregabalin, the gabapentin group in which the patients received 1200mg gabapentin, or the control group in which the patients received placebo 2h prior to surgery. Postoperative pain was controlled with intravenous fentanyl via patient controlled analgesia (PCA). Fentanyl consumption over 24 h and pain intensity measured by visual analogue score at rest (static) and during cough (dynamic) at recovery time, 1, 2, 6, 12, and 24h were recorded. Also sedation status, somnolence, dizziness, headache, nausea, and vomiting were monitored. Results Postoperative 24 h fentanyl consumption was significantly higher in the control group compared with both pregabalin and gabapentin groups (P<0.001). Pain intensity on visual analogue score (static and dynamic) was significantly higher in the control group compared with both pregabalin and gabapentin groups at time of recovery, 1, 2, 6, 12, and 24 h postoperatively. Numeric sedation score was significantly lower in the control group compared with pregabalin and gabapentin groups at time of recovery, 1, 2, and 6h postoperatively. No significant differences were found among the three groups as regards somnolence, dizziness, headache, nausea, and vomiting. Conclusion A single dose of 300mg pregabalin or 1200mg gabapentin given 2 h before surgery is better than placebo for postoperative pain control for laparoscopic gastric bypass surgery without significant side effects.
术前普瑞巴林与加巴喷丁对腹腔镜胃旁路手术术后疼痛控制的影响
©2018 Ain-Shams麻醉学杂志|出版背景围手术期加巴喷丁有助于产生显著的阿片类药物节约效果,也可能改善术后疼痛评分。普瑞巴林是一种新型药物,在镇痛、镇静、抗焦虑和阿片类药物保护作用方面具有很高的研究兴趣,在各种情况下,包括术后疼痛。我们研究了普瑞巴林在腹腔镜胃旁路手术后急性疼痛的病态肥胖患者中的镇痛效果,并将其与加巴喷丁和安慰剂进行了比较。患者和方法对90例接受腹腔镜胃旁路手术的病态肥胖患者进行随机、安慰剂对照研究。患者被分为三组之一;普瑞巴林组患者接受300mg普瑞巴林,加巴喷丁组患者接受1200mg加巴喷丁,或对照组患者在手术前2h接受安慰剂。术后通过患者自控镇痛(PCA)静脉注射芬太尼控制疼痛。记录24h内芬太尼用量及恢复时间(1、2、6、12、24h)静息(静态)和咳嗽(动态)时视觉模拟评分测量疼痛强度。同时监测镇静状态、嗜睡、头晕、头痛、恶心和呕吐。结果对照组术后24 h芬太尼用量明显高于普瑞巴林组和加巴喷丁组(P<0.001)。恢复时、术后1、2、6、12、24 h,对照组视觉模拟评分(静态和动态)疼痛强度均显著高于普瑞巴林组和加巴喷丁组。在恢复时、术后1、2、6h,对照组的数值镇静评分明显低于普瑞巴林组和加巴喷丁组。三组患者在嗜睡、头晕、头痛、恶心和呕吐方面无显著差异。结论术前2 h单剂量普瑞巴林300mg或加巴喷丁1200mg对腹腔镜胃旁路手术术后疼痛的控制效果优于安慰剂,且无明显副作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。